Cite
HARVARD Citation
Keresztes, D. et al. (2022). Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer. Journal of cellular and molecular medicine. 26 (4), pp. 1332-1337. [Online].